CAGGIU, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 352
EU - Europa 219
AS - Asia 124
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 698
Nazione #
US - Stati Uniti d'America 349
CN - Cina 83
UA - Ucraina 80
IT - Italia 50
DE - Germania 31
FR - Francia 25
SG - Singapore 23
SE - Svezia 12
FI - Finlandia 10
KR - Corea 7
GB - Regno Unito 5
IN - India 4
BE - Belgio 3
CA - Canada 3
HK - Hong Kong 2
IR - Iran 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
Totale 698
Città #
Chandler 100
Jacksonville 50
Princeton 27
Dearborn 23
Sassari 20
Nanjing 19
Singapore 19
Wilmington 18
New York 12
Beijing 8
Ashburn 7
Nanchang 7
Seoul 7
Changsha 6
Jiaxing 6
Norwalk 6
Shenyang 6
Mountain View 5
Cagliari 4
Hangzhou 4
Brussels 3
Guangzhou 3
Hebei 3
Helsinki 3
Jinan 3
Ningbo 3
Rome 3
San Mateo 3
Santa Clara 3
Tianjin 3
Ann Arbor 2
Boardman 2
Frankfurt am Main 2
London 2
Munich 2
Olbia 2
Shanghai 2
St Louis 2
Taizhou 2
Toronto 2
Alghero 1
Ardabil 1
Brno 1
Central 1
Fuzhou 1
Hyderabad 1
Izmir 1
Madrid 1
Milan 1
Monmouth Junction 1
Ottawa 1
Quartu Sant'elena 1
San Francisco 1
Shenzhen 1
Sydney 1
Torino 1
Vienna 1
Woodbridge 1
Wuhu 1
Zhengzhou 1
Totale 424
Nome #
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 65
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 62
Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study 62
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 62
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients 58
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 57
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease 54
High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients 54
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease? 48
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease? 48
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 48
Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in Iranian patients 47
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients 44
Parkinson's disease: Immune System, infections and Alpha-synuclein protein 28
Totale 737
Categoria #
all - tutte 3.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 2 14 20 22 6 14 8 15 0
2020/2021111 13 0 15 0 14 2 13 5 16 16 12 5
2021/202278 7 2 0 2 0 0 2 7 9 6 17 26
2022/2023173 13 19 10 24 19 26 0 16 27 1 5 13
2023/202463 9 4 2 1 12 11 0 9 0 2 10 3
2024/202552 3 0 27 22 0 0 0 0 0 0 0 0
Totale 737